(Q38518891)

3 September 2017

title

Serum oxidized low-density lipoproteins in rheumatoid arthritis (English)

1 reference

3 September 2017

0 references

Seong-Ho Kim

1

1 reference

3 September 2017

Chang-Keun Lee

2

1 reference

3 September 2017

Eun Young Lee

3

1 reference

3 September 2017

So Yeon Park

4

1 reference

3 September 2017

You Sook Cho

5

1 reference

3 September 2017

Bin Yoo

6

1 reference

3 September 2017

Hee-Bom Moon

7

1 reference

3 September 2017

publication date

20 November 2003

1 reference

Rheumatology International

3 September 2017

published in

1 reference

3 September 2017

volume

24

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

230-233

1 reference

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

3 September 2017

cites work

1 reference

12 December 2020

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

1 reference

12 December 2020

Lipid profiles in untreated patients with rheumatoid arthritis

1 reference

12 December 2020

Transcriptional regulation of ceruloplasmin gene expression during inflammation

1 reference

12 December 2020

Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis

1 reference

12 December 2020

Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure

1 reference

12 December 2020

Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins

1 reference

12 December 2020

Risk factors for cardiovascular disease in systemic lupus erythematosus

1 reference

12 December 2020

Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis

1 reference

12 December 2020

Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis

1 reference

12 December 2020

A Modified Form of Low-Density Lipoprotein with Increased Electronegative Charge is Present in Rheumatoid Arthritis Synovial Fluid

1 reference

12 December 2020

A comparison of the suppression of human transferrin synthesis by lead and lipopolysaccharide

1 reference

12 December 2020

Infection and inflammation induce LDL oxidation in vivo

1 reference

12 December 2020

Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids

1 reference

12 December 2020

The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms

1 reference

12 December 2020

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

1 reference

12 December 2020

Low density lipoprotein of synovial fluid in inflammatory joint disease is mildly oxidized.

1 reference

12 December 2020

Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis

1 reference

12 December 2020

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

1 reference

12 December 2020

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins

1 reference

12 December 2020

Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.

1 reference

12 December 2020

Oxidized LDL and HDL: antagonists in atherothrombosis

1 reference

12 December 2020

Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.

1 reference

12 December 2020

Comorbidity in arthritis.

1 reference

12 December 2020

The mortality of rheumatoid arthritis

1 reference

12 December 2020

Clinical significance of antibodies against oxidised low density lipoprotein in early RA.

1 reference

12 December 2020

Dyslipidemia and rheumatoid arthritis

1 reference

12 December 2020

Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome

1 reference

12 December 2020

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

12 December 2020

10.1007/S00296-003-0358-4

Identifiers

DOI

0 references

Dimensions Publication ID

1027582115

0 references

1 reference